Archive

Metformin reduces Afib after ablation

Written by Bruce Sylvester | 16 Nov 2025

Obese or overweight non-diabetic adults with atrial fibrillation (Afib) who take the diabetes medication metformin after a catheter ablation are more likely to remain free of AFib for… read more.

Wegovy users achieved waist and BMI targets linked to improved health and low risk of obesity-related complications – Novo Nordisk

Written by Charlie King | 14 Nov 2025

At ObesityWeek taking place in Atlanta, US, Novo Nordisk presented new findings from the STEP UP phase IIIb trial. It showed that, in addition to losing an average… read more.

MetaVia to share latest research on DA-1726 for obesity and metabolic disorders at ObesityWeek 2025

Written by Charlie King | 23 Oct 2025

MetaVia Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, announced that two abstracts highlighting data on DA-1726, a novel, dual oxyntomodulin (OXM) analog agonist that functions as… read more.

Study indicates dramatic increase in percentage of US adults who meet new definition of obesity

Written by Charlie King | 22 Oct 2025

The prevalence of obesity in the United States could rise sharply under a new definition of obesity released earlier this year by the Lancet Diabetes and Endocrinology Commission. Researchers… read more.

Half of patients taking weight-loss drug quit within a year

Written by Gary Finnegan | 27 Sep 2025

More than half of all adults without diabetes who began taking semaglutide discontinued treatment within a year, according to new research on Danish patients. The population-wide study was… read more.

Half of people stop taking popular weight-loss drug within a year, national study finds

Written by Charlie King | 20 Sep 2025

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight. However, a new population-wide study being presented at… read more.

NICE (UK) positive for tirzepatide for managing overweight and obesity – Eli Lilly

Written by Charlie King | 5 Sep 2025

NICE (UK): Tirzepatide is recommended as an option for managing overweight and obesity, alongside a reduced-calorie diet and increased physical activity in adults, only if they have: i)… read more.

One in seven bariatric surgery patients turn to new weight loss drugs

Written by Charlie King | 31 Aug 2025

Bariatric surgery is usually effective on its own for weight loss, but an increasing proportion of patients who undergo bariatric surgery start taking one of the new glucagon-like… read more.

Obese surgical patients’ medication lifeline can reduce risk – study

Written by Charlie King | 20 Aug 2025

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of surgical complications linked to their obesity, a new study… read more.

Less processed diet may be more beneficial for weight loss

Written by Charlie King | 12 Aug 2025

When given nutritionally matched diets, participants lost twice as much weight eating minimally processed foods compared to ultra-processed foods, suggesting that cutting down on processing could help to… read more.

Nearly 12% of Americans have used GLP-1 weight loss drugs

Written by Charlie King | 11 Aug 2025

Nearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64, according to a new RAND report. Surveying a nationally… read more.

Metformin linked to lower risk of dementia and death in obese patients

Written by Bruce Sylvester | 9 Aug 2025

Use of the diabetes drug metformin appears to be linked to reduced risk of dementia and death in obese patients, researchers reported on August 6, 2025 in Diabetes,… read more.

1 2 3 … 20 Next »

Archive

Subscribe for our mailing list

Follow Us